E. Jason Abel, M.D., F.A.C.S.
Associate Professor of Urology, University of Wisconsin School of Medicine and Public Health
Daniel George, M.D.
Professor, Medicine and Surgery, Divisions of Medical Oncology and Urology, Duke University School of Medicine; Director of Genitourinary Oncology, Duke Cancer Institute
Rana McKay, M.D.
Associate Professor of Medicine and Urology, University of California, San Diego; Co-Leader of Genitourinary Oncology Disease Team, Moores Cancer Center
Dror Michaelson, M.D., Ph.D. (Chair)
Assoc. Professor of Medicine, Harvard Medical School; Director, Genitourinary Cancer Center, Massachusetts General Hospital
Elizabeth Plimack, M.D., M.S.
Professor of Hematology/Oncology and Division Chief of Genitourinary Medical Oncology, Fox Chase Cancer Center
Mark Ratain, M.D.
Professor of Medicine, University of Chicago; Director of the Center for Personalized Therapeutics and Associate Director for Clinical Sciences, University of Chicago Comprehensive Cancer Center; Chief of Hospital Pharmacology, University of Chicago Medical Center
Brian Rini, M.D.
Professor of Medicine and Chief of Clinical Trials, Vanderbilt-Ingram Cancer Center
Yu Shyr, Ph.D.
Professor of Biostatistics and Biomedical Informatics and Cancer Biology and Health Policy and Chair, Biostatistics, Vanderbilt University Medical Center; Director, Vanderbilt Center for Quantitative Sciences; Director, Vanderbilt Technologies for Advanced Genomics Analysis and Research Design; Associate Director, Quantitative Sciences Integration, Vanderbilt-Ingram Cancer Center
M. Celeste Simon, Ph.D.
Professor of Cell and Developmental Biology, University of Pennsylvania School of Medicine; Scientific Director, Abramson Family Cancer Research Institute